BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 16615525)

  • 1. [Development of drug-resistant human cytomegalovirus].
    Murayama T
    Nihon Rinsho; 2006 Mar; 64 Suppl 3():508-11. PubMed ID: 16615525
    [No Abstract]   [Full Text] [Related]  

  • 2. [Mechanism of drug-resistance in human cytomegalovirus].
    Eizuru Y
    Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():476-9. PubMed ID: 17455666
    [No Abstract]   [Full Text] [Related]  

  • 3. Ganciclovir resistance mutations in UL97 and UL54 genes of Human cytomegalovirus isolates resistant to ganciclovir.
    Foulongne V; Turrière C; Diafouka F; Abraham B; Lastere S; Segondy M
    Acta Virol; 2004; 48(1):51-5. PubMed ID: 15230476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation and characterization of a GCV resistant HCMV UL97-mutation and a drug sensitive UL54-mutation.
    Fischer L; Laib Sampaio K; Jahn G; Hamprecht K; Göhring K
    Antiviral Res; 2013 Dec; 100(3):575-7. PubMed ID: 24120366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel mutation in the UL54 gene of human cytomegalovirus isolates that confers resistance to foscarnet.
    Ducancelle A; Champier G; Alain S; Petit F; Le Pors MJ; Mazeron MC
    Antivir Ther; 2006; 11(4):537-40. PubMed ID: 16856628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analysis of ganciclovir-resistant cytomegalovirus].
    Eizuru Y
    Nihon Rinsho; 1998 Jan; 56(1):151-5. PubMed ID: 9465681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrasting effects on ganciclovir susceptibility and replicative capacity of two mutations at codon 466 of the human cytomegalovirus UL97 gene.
    Martin M; Goyette N; Boivin G
    J Clin Virol; 2010 Dec; 49(4):296-8. PubMed ID: 20843736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maribavir sensitivity of cytomegalovirus isolates resistant to ganciclovir, cidofovir or foscarnet.
    Drew WL; Miner RC; Marousek GI; Chou S
    J Clin Virol; 2006 Oct; 37(2):124-7. PubMed ID: 16962820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytomegalovirus antiviral resistance associated with treatment induced UL97 (protein kinase) and UL54 (DNA polymerase) mutations.
    Scott GM; Isaacs MA; Zeng F; Kesson AM; Rawlinson WD
    J Med Virol; 2004 Sep; 74(1):85-93. PubMed ID: 15258973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opposite effect of two cytomegalovirus DNA polymerase mutations on replicative capacity and polymerase activity.
    Martin M; Azzi A; Lin SX; Boivin G
    Antivir Ther; 2010; 15(4):579-86. PubMed ID: 20587851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and biologic aspects of human cytomegalovirus resistance to antiviral drugs.
    Baldanti F; Lurain N; Gerna G
    Hum Immunol; 2004 May; 65(5):403-9. PubMed ID: 15172438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viral DNA polymerase mutations associated with drug resistance in human cytomegalovirus.
    Chou S; Lurain NS; Thompson KD; Miner RC; Drew WL
    J Infect Dis; 2003 Jul; 188(1):32-9. PubMed ID: 12825168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of resistance-associated HCMV UL97- and UL54-mutations and a UL97-polymporphism with impact on phenotypic drug-resistance.
    Fischer L; Imrich E; Sampaio KL; Hofmann J; Jahn G; Hamprecht K; Göhring K
    Antiviral Res; 2016 Jul; 131():1-8. PubMed ID: 27058773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multidrug resistance conferred by novel DNA polymerase mutations in human cytomegalovirus isolates.
    Scott GM; Weinberg A; Rawlinson WD; Chou S
    Antimicrob Agents Chemother; 2007 Jan; 51(1):89-94. PubMed ID: 17043128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid detection directly from patient serum samples of human cytomegalovirus UL97 mutations conferring ganciclovir resistance.
    Castor J; Cook L; Corey L; Jerome KR
    J Clin Microbiol; 2007 Aug; 45(8):2681-3. PubMed ID: 17537934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [In vitro susceptibility to ganciclovir and foscarnet of cytomegaloviruses].
    Otegui M; Rabella N; Labeaga R; Herrero M; Margall R; Muñoz JM; Prats G
    Rev Esp Quimioter; 2001 Jun; 14(2):155-64. PubMed ID: 11704769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of resistance-associated mutations in UL54 and UL97 genes of circulating cytomegalovirus strains isolated in a medical center in Taiwan.
    Shao PL; Lu MY; Liau YJ; Kao CL; Chang SY; Huang LM
    J Formos Med Assoc; 2012 Aug; 111(8):456-60. PubMed ID: 22939665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation in region III of the DNA polymerase gene conferring foscarnet resistance in cytomegalovirus isolates from 3 subjects receiving prolonged antiviral therapy.
    Chou S; Marousek G; Parenti DM; Gordon SM; LaVoy AG; Ross JG; Miner RC; Drew WL
    J Infect Dis; 1998 Aug; 178(2):526-30. PubMed ID: 9697736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid simultaneous detection by real-time PCR of cytomegalovirus UL97 mutations in codons 460 and 520 conferring ganciclovir resistance.
    Göhring K; Mikeler E; Jahn G; Hamprecht K
    J Clin Microbiol; 2006 Dec; 44(12):4541-4. PubMed ID: 17035493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance to antivirals in human cytomegalovirus: mechanisms and clinical significance.
    Pérez JL
    Microbiologia; 1997 Sep; 13(3):343-52. PubMed ID: 9353754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.